title: Characterization of prostaglandin E receptors in canine small intestine using [3H] prostaglandin E1 binding.
abstract: Prostaglandin E (PGE) receptors in canine small intestinal mucosal and muscle membrane preparations were labeled with [3H] PGE1. Saturable, high affinity binding of [3H] PGE1 was observed in both preparations. The density of binding sites (fmol/mg protein) was 39 for mucosal membranes and 60 for muscle membranes, with corresponding dissociation constants of 10.6 nM and 5.8 nM, respectively. [3H] PGE1 binding sites in both preparations showed stereospecificity and high affinity for natural PGE1 and PGE2, but not for I or F-type PGs. Synthetic PGEs such as misoprostol and enisoprost had lower affinity than PGE1 or PGE2. Several analogs of enisoprost bound weakly to the binding sites. A highly significant correlation (C.C. = 0.9) was demonstrated between mucosal and muscle binding potency for a series of enisoprost analogs. There was also a significant positive correlation between the receptor binding potency and rat diarrheagenic activity for these analogs. These results indicate that PGE receptors in canine intestinal mucosa and muscle can be directly studied with [3H] PGE1 binding. The mucosal and muscle PGE receptors may have similar ligand binding specificity. We speculate that these receptors are likely to be associated with the diarrheagenic activity of PGEs.
authors.affiliation: Immunoinflammatory Diseases Research, Searle, Skokie, IL 60077.
authors.forename: R H
authors.initials: RH
authors.lastname: Keith
authors.forename: B S
authors.initials: BS
authors.lastname: Tsai
authors.forename: P W
authors.initials: PW
authors.lastname: Collins
authors.forename: W E
authors.initials: WE
authors.lastname: Perkins
authors.forename: R L
authors.initials: RL
authors.lastname: Shone
authors.forename: A F
authors.initials: AF
authors.lastname: Gasiecki
authors.forename: R G
authors.initials: RG
authors.lastname: Bianchi
authors.forename: R F
authors.initials: RF
authors.lastname: Bauer
mesh_terms: D000527:Alprostadil / Q000031:analogs & derivatives / Q000378:metabolism* / Q000494:pharmacology; D000818:Animals; D000897:Anti-Ulcer Agents / Q000494:pharmacology; D003967:Diarrhea / Q000139:chemically induced; D004285:Dogs; D007421:Intestine, Small / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D016595:Misoprostol / Q000494:pharmacology; D015394:Molecular Structure; D051381:Rats; D011982:Receptors, Prostaglandin / Q000187:drug effects / Q000378:metabolism*; D018078:Receptors, Prostaglandin E; D012680:Sensitivity and Specificity; D014316:Tritium
chemical_list: D000897:Anti-Ulcer Agents; D011982:Receptors, Prostaglandin; D018078:Receptors, Prostaglandin E; D016595:Misoprostol; D014316:Tritium; D000527:Alprostadil; C054594:enisoprost